Elena Prokopyeva | Immunology and Microbiology | Life Sciences Innovation Award

Dr. Elena Prokopyeva | Immunology and Microbiology | Life Sciences Innovation Award

Senior Researcher of Novosibirsk state university, Russia.

Elena Prokopyeva is a distinguished researcher and educator based at the Federal Research Center of Fundamental and Translational Medicine in Novosibirsk, Russia. Her academic journey began at Novosibirsk State University and progressed through advanced research positions at institutions like the FBRI State Research Center of Virology and Biotechnology ‘Vector’. Dr. Prokopyeva holds a PhD focused on the phenotypic and genotypic properties of influenza viruses and has made significant contributions to virology, studying various viruses including influenza, coronaviruses, and adenoviruses. Her expertise extends to virological methods, immunohistochemistry, and serological diagnostics. Dr. Prokopyeva has authored numerous high-impact publications, reflecting her extensive research in infectious diseases and cell biology. She is also a reviewer for MDPI and an expert for the Russian Science Foundation. Her achievements, coupled with her teaching roles in embryology and histology, underscore her valuable contributions to the scientific community.

Profile
Education

Elena Prokopyeva completed her undergraduate studies at Novosibirsk State University (NSU) from 2003 to 2009, where she specialized in Natural Science with a focus on Physiology. She pursued her graduate studies at the Institute of Molecular Biology and Biophysics, Siberian Branch of the Russian Academy of Medical Sciences, from 2009 to 2010, earning expertise in Biochemistry. Her research career began in earnest at the FBRI State Research Center of Virology and Biotechnology ‘Vector’, where she was a Researcher Graduate student from 2010 to 2013, focusing on Virology and Cell Biology. Prokopyeva earned her PhD in December 2015 from the same center, with a thesis on the phenotypic and genotypic properties of pandemic influenza A(H1N1)pdm09 virus. She has continued her academic and research activities at the Federal Research Center of Fundamental and Translational Medicine since 2013.

Professional Experience

Elena Prokopyeva has a distinguished career in virology and molecular biology, marked by extensive research and teaching roles. She began her academic journey at Novosibirsk State University, where she pursued undergraduate studies in natural science and later advanced her education with a PhD at the State Research Center of Virology and Biotechnology ‘Vector’. Her professional experience includes significant roles as a researcher at the Federal Research Center of Fundamental and Translational Medicine (FRC FTM) and as a lecturer in “Embryology,” “General Histology,” and “Special Histology” at Novosibirsk State University. Prokopyeva’s expertise spans virological methods, immunofluorescence, and serological diagnostics, with a focus on infectious diseases and cell biology. She has also contributed as a reviewer for MDPI and an expert for the Russian Science Foundation, reflecting her influence in the scientific community.

Research Interest

Elena Prokopyeva’s research primarily focuses on virology, particularly the study of influenza and other respiratory viruses. Her work explores the phenotypic and genotypic properties of pandemic influenza strains and their adaptation in various animal models. Prokopyeva has conducted significant research on the genetic diversity of adenoviruses and the impact of SARS-CoV-2 on respiratory infections in children. Her expertise extends to the characterization of avian and human respiratory viruses, including their interaction with host cells and susceptibility to antiviral treatments. Additionally, Prokopyeva investigates the molecular mechanisms underlying viral pathogenesis and employs advanced techniques such as immunofluorescence, real-time PCR, and electron microscopy to enhance the understanding of infectious diseases. Her contributions aim to improve diagnostic methods and therapeutic strategies for viral infections, reflecting her commitment to advancing the field of virology and infectious disease research.

Research Skills

Elena Prokopyeva possesses a diverse and advanced skill set in research, particularly within virology and infectious diseases. Her expertise includes virological methods such as virus isolation, infection assays, and the determination of virus susceptibility to inhibitors. She is adept in immunofluorescence and immunohistochemistry techniques, essential for studying viral interactions and pathogenesis. Prokopyeva’s proficiency extends to serological diagnostics using hemagglutination and microneutralization assays, as well as molecular techniques like RNA/DNA isolation, real-time PCR, and gel electrophoresis. Her experience with light and electron microscopy further enhances her capability to analyze viral structures and disease mechanisms. Prokopyeva’s role as a reviewer and expert for scientific foundations highlights her strong analytical skills and contributions to advancing the field of virology. Her comprehensive research skills, combined with her active participation in professional organizations, underscore her significant impact and ongoing commitment to her field.

Awards and Recognition

Elena Prokopyeva has earned notable recognition for her research in virology and infectious diseases. Her contributions to the field are highlighted by her role as a reviewer for the MDPI and an expert for the Russian Science Foundation, reflecting her expertise and impact on scientific research. Her work has been published in prestigious journals such as Viruses, Biochemistry (Moscow), and the Journal of Infection in Developing Countries, with high citation rates in Web of Science and Scopus. Prokopyeva’s research on influenza viruses and other pathogens has garnered significant attention, underscoring her expertise in studying viral genetic diversity and pathogenic mechanisms. Additionally, her involvement with the Euro-Asian Society for Infectious Diseases marks her as a key figure in advancing knowledge in her field. These accolades affirm her standing as a distinguished researcher and contribute to her recognition for the Best Researcher Award.

Conclusion

Elena Prokopyeva is a strong candidate for the Best Researcher Award due to her extensive research expertise, impressive publication record, and significant contributions to the field of virology. Her work in understanding and combating viral diseases, coupled with her role in educating future scientists, underscores her value as a researcher. Addressing the areas for improvement could further enhance her standing and impact in the scientific community. Overall, Prokopyeva’s achievements and ongoing contributions make her a worthy candidate for the award.

Publications Top Notes

  • “Genetic Diversity of the Human Adenovirus C Isolated from Hospitalized Children in Russia (2019–2022)”
    • Authors: Kurskaya, O.G., Prokopyeva, E.A., Dubovitskiy, N.A., Shestopalov, A.M., Sharshov, K.A.
    • Journal: Viruses
    • Year: 2024
    • Volume: 16(3)
    • Article Number: 386
    • Citations: 1
  • “Constitutive Androstane Receptor Agonist Initiates Metabolic Activity Required for Hepatocyte Proliferation”
    • Authors: Mazin, M.E., Perevalova, A.M., Yarushkin, A.A., Gulyaeva, L.F., Pustylnyak, V.O.
    • Journal: Biochemistry (Moscow)
    • Year: 2023
    • Volume: 88(8)
    • Pages: 1061–1069
  • “Changes in the Etiology of Acute Respiratory Infections among Children in Novosibirsk, Russia, between 2019 and 2022: The Impact of the SARS-CoV-2 Virus”
    • Authors: Kurskaya, O.G., Prokopyeva, E.A., Sobolev, I.A., Shestopalov, A.M., Sharshov, K.A.
    • Journal: Viruses
    • Year: 2023
    • Volume: 15(4)
    • Article Number: 934
    • Citations: 8
  • “Virological and Genetic Characterization of the Unusual Avian Influenza H14Nx Viruses in the Northern Asia”
    • Authors: Dubovitskiy, N., Derko, A., Sobolev, I., Shestopalov, A., Sharshov, K.
    • Journal: Viruses
    • Year: 2023
    • Volume: 15(3)
    • Article Number: 734
    • Citations: 1
  • “Virological and genetic characteristics of human respiratory syncytial viruses isolated in Russia, 2017-2018”
    • Authors: Prokopyeva, E.A., Kurskaya, O.G., Solomatina, M.V., Shestopalov, A.M., Sharshov, K.A.
    • Journal: Journal of Infection in Developing Countries
    • Year: 2023
    • Volume: 17(2)
    • Pages: 251–259
    • Citations: 2
  • “Promotion of NR1I3-mediated liver growth is accompanied by STAT3 activation”
    • Authors: Mazin, M.E., Yarushkin, A.A., Pustylnyak, Y.A., Prokopyeva, E.A., Pustylnyak, V.O.
    • Journal: Molecular Biology Reports
    • Year: 2022
    • Volume: 49(5)
    • Pages: 4089–4093
    • Citations: 2
  • “Low incidence of human coronavirus among hospitalized children in Novosibirsk city, Russia during pre-pandemic period (2013–2020)”
    • Authors: Kurskaya, O.G., Prokopyeva, E.A., Anoshina, A.V., Shestopalov, A.M., Sharshov, K.A.
    • Journal: Journal of Microbiology, Immunology and Infection
    • Year: 2022
    • Volume: 55(2)
    • Pages: 336–340
    • Citations: 3
  • “Anti-Influenza Activity of Medicinal Material Extracts from Qinghai–Tibet Plateau”
    • Authors: Kurskaya, O., Prokopyeva, E., Bi, H., Wei, L., Sharshov, K.
    • Journal: Viruses
    • Year: 2022
    • Volume: 14(2)
    • Article Number: 360
    • Citations: 7
  • “Etiology of influenza-like illnesses in the population of Novosibirsk City in the 2018-2019 epidemic season”
    • Authors: Kurskaya, O.G., Anoshina, A.V., Leonova, N.V., Shestopalov, A.M., Sharshov, K.A.
    • Journal: Russian Journal of Infection and Immunity
    • Year: 2021
    • Volume: 11(4)
    • Pages: 723–736
    • Citations: 2
  • “Activation of the Akt pathway by a constitutive androstane receptor agonist results in β-catenin activation”
    • Authors: Yarushkin, A.A., Mazin, M.E., Pustylnyak, Y.A., Prokopyeva, E.A., Pustylnyak, V.O.
    • Journal: European Journal of Pharmacology
    • Year: 2020
    • Volume: 879
    • Article Number: 173135
    • Citations: 6

 

Muhammad Adnan Shereen | Immunology Award | Best Researcher Award

Dr. Muhammad Adnan Shereen | Immunology Award | Best Researcher Award

Research Associate at Feinbeg School of Medicine, Northwestern University, Chicago, IL, USA

Dr. Muhammad Adnan Shereen is a highly accomplished researcher and educator with expertise in microbiology, virology, immunology, and molecular biology. He completed his Ph.D. in Microbiology (Virology) from Wuhan University, China, focusing on the dysregulation of astrocytic genes by the Zika virus. Dr. Shereen has received several prestigious awards and recognitions for his academic achievements, including being ranked among the top 2% most influential scientists in the world by Stanford University. He has published extensively on various aspects of virology and infectious diseases, including the COVID-19 pandemic. Dr. Shereen’s research interests include neurotropic viruses, host-pathogen interactions, and the development of therapeutic options for viral infections. He has a strong background in scientific skills, including culturing and identifying pathogenic microbes, sequencing, animal modeling, and various molecular techniques. Dr. Shereen has also gained teaching experience and has been involved in research supervision at multiple institutions, demonstrating his commitment to education and academic excellence.

Professional Profiles:

Education:

Dr. Muhammad Adnan Shereen pursued his Ph.D. in Microbiology (Virology) from September 2017 to June 2021 at the State Key Laboratory of Virology, Department of Microbiology, College of Life Sciences, Wuhan University, China. His dissertation focused on the dysregulation of astrocytic genes involved in neurodevelopment by the Zika virus. Prior to his Ph.D., Dr. Shereen completed his M.Phil. in Microbiology from September 2013 to June 2015 at the Institute of Basic Medical Sciences, Khyber Medical University, Peshawar, Pakistan. His M.Phil. dissertation involved the synthesis and characterization of Miltefosine Loaded Thiolated Nanoparticles for Leishmaniasis Therapy. He obtained his Bachelor of Science (Hons) in Microbiology from The University of Peshawar, Pakistan, from 2009 to 2013. Additionally, Dr. Shereen completed his Higher Secondary School Certificate (Pre-Medical) from Peshawar Model Degree College, Peshawar, Pakistan, from 2005 to 2007.

Professional Experience:

Dr. Muhammad Adnan Shereen is currently a Research Associate/Postdoctoral at the Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, USA. He also serves as a Research Lecturer at Kohsar University of Murree, Pakistan, where he supervises research and teaches various subjects in the Department of Microbiology. Previously, he worked as a Research Lecturer at the University of Haripur, Pakistan, where he also supervised research and taught microbiology-related subjects. During his Ph.D., Dr. Shereen worked as a Research Associate in Professor Jianguo Wu’s lab at the State Key Laboratory of Virology. He has also participated in the CSCB Training Course on Mouse Genetics and Phenotyping, organized by the Model Animal Research Center, Nanjing University, China, and the Chinese Society for Cell Biology. Earlier in his career, Dr. Shereen served as a Demonstrator at Jinnah Medical College, Peshawar, Pakistan, where he taught General Bacteriology, Immunology, and Parasitology. He also gained valuable experience as an Internee at Govt. Lady Reading Hospital, Peshawar, Pakistan, where he worked in the Pathology department, focusing on microbiology, serology, PCR, and ELISA.

Research Interest:

Dr. Muhammad Adnan Shereen possesses a diverse skill set in the field of microbiology and related disciplines. His expertise includes microbiology, virology, molecular biology, and immunology, reflecting a comprehensive understanding of microbial pathogens and their interactions with host organisms. Dr. Shereen is proficient in cell and tissue culture technology, which is crucial for studying the behavior of cells in controlled environments. He has experience in isolating primary cells, a fundamental technique in cell biology and immunology research. His knowledge extends to innate immunity, the body’s first line of defense against pathogens, and the complex interactions between hosts and pathogens. Dr. Shereen is skilled in animal modeling, an essential tool for studying diseases and testing potential treatments in vivo. Additionally, he is adept at bioinformatic analysis, enabling him to process and interpret complex biological data. Overall, Dr. Shereen’s broad range of skills makes him a valuable asset in research settings focused on microbiology and related fields.

Awards and Recognitions:

Dr. Muhammad Adnan Shereen has been recognized for his outstanding contributions and achievements in the field of microbiology and virology. He was ranked among the top 2% most influential scientists in the world by Stanford University in both 2022 and 2023, highlighting the impact of his research and expertise. He was awarded the Chinese Government Scholarship under CSC NO. 2016GXYC42 for his Ph.D. studies, receiving a fully funded scholarship from 2017 to 2021. This prestigious scholarship reflects his academic excellence and dedication to research. Dr. Shereen’s academic achievements were further acknowledged by Wuhan University, where he was the First Prize Winner in Academic Achievement for the year 2020. He also won the “Virology Youth Innovation Award” in 2021 for the highest number of publications during his Ph.D. In recognition of his efforts during the COVID-19 pandemic, Dr. Shereen was honored as one of the “Wuhan University 8 Outstanding Individuals to Fight against Coronavirus,” highlighting his commitment to scientific advancement and public health. He has also received several other awards, including the “Excellent International Student Scholarship for the Year 2018” and the “CSCB Training Course on Mouse Genetics and Phenotyping” certificate, demonstrating his continuous pursuit of excellence in academia and research. Additionally, Dr. Shereen has been acknowledged for his academic prowess, standing as the 2nd position holder in his M.Phil. batch from 2013 to 2015. His acceptance and invitation letters for Ph.D. programs at Huazhong University of Science and Technology and Wuhan University further attest to his academic standing and research potential.

Skills:

Dr. Muhammad Adnan Shereen possesses excellent scientific skills, particularly in Microbiology, Virology, Immunology, and Molecular Biology. He is proficient in culturing and identifying pathogenic microbes, primary cell isolation, various microscopy techniques, sequencing, animal modeling, and molecular biology techniques such as PCRs, blotting assays, and ELISA. Dr. Shereen is also skilled in DNA, RNA, protein, and plasmid extractions, transfection, synthesis of biomaterials, and drug-loaded nanoparticles. His expertise makes him a valuable researcher in biomedical sciences.

Publications:

  1. COVID-19 infection: Emergence, transmission, and characteristics of human coronaviruses
    • Authors: MA Shereen, S Khan, A Kazmi, N Bashir, R Siddique
    • Year: 2020
    • Citations: 5591
  2. Emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2: biology and therapeutic options
    • Authors: S Khan, R Siddique, MA Shereen, A Ali, J Liu, Q Bai, N Bashir, M Xue
    • Year: 2020
    • Citations: 436
  3. Impact of coronavirus outbreak on psychological health
    • Authors: S Khan, R Siddique, H Li, A Ali, MA Shereen, N Bashir, M Xue
    • Year: 2020
    • Citations: 316
  4. HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19
    • Authors: M Tian, W Liu, X Li, P Zhao, MA Shereen, C Zhu, S Huang, S Liu, X Yu, …
    • Year: 2021
    • Citations: 151
  5. STING promotes NLRP3 localization in ER and facilitates NLRP3 deubiquitination to activate the inflammasome upon HSV-1 infection
    • Authors: W Wang, D Hu, C Wu, Y Feng, A Li, W Liu, Y Wang, K Chen, M Tian, …
    • Year: 2020
    • Citations: 126
  6. Novel coronavirus: how things are in Wuhan
    • Authors: S Khan, G Nabi, G Han, R Siddique, S Lian, H Shi, N Bashir, A Ali, …
    • Year: 2020
    • Citations: 85
  7. The spread of novel coronavirus has created an alarming situation worldwide
    • Authors: S Khan, R Siddique, A Ali, Q Bai, Z Li, H Li, MA Shereen, M Xue, G Nabi
    • Year: 2020
    • Citations: 71
  8. EV71 infection induces neurodegeneration via activating TLR7 signaling and IL-6 production
    • Authors: Z Luo, R Su, W Wang, Y Liang, X Zeng, MA Shereen, N Bashir, Q Zhang, …
    • Year: 2019
    • Citations: 68
  9. Breastfeeding risk from detectable severe acute respiratory syndrome coronavirus 2 in breastmilk
    • Authors: C Zhu, W Liu, H Su, S Li, MA Shereen, Z Lv, Z Niu, D Li, F Liu, Z Luo, …
    • Year: 2020
    • Citations: 60
  10. The comparative superiority of IgM-IgG antibody test to real-time reverse transcriptase PCR detection for SARS-CoV-2 infection diagnosis
    • Authors: R Liu, X Liu, H Han, MA Shereen, Z Niu, D Li, F Liu, K Wu, Z Luo, C Zhu
    • Year: 2020
    • Citations: 53